194
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Combination Treatment for Glioblastoma Cells with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Oncolytic Adenovirus Delta-24

, , &
Pages 630-638 | Received 03 Jun 2013, Accepted 18 Sep 2013, Published online: 28 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

George A. Alexiou, Paraskevi Gerogianni, Evrysthenis Vartholomatos & Athanasios P. Kyritsis. (2016) Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells. Cancer Investigation 34:10, pages 489-495.
Read now

Articles from other publishers (13)

Athina Malliou, Athanasios P. Kyritsis & George A. Alexiou. 2022.
Vasiliki Zoi, Vasiliki Galani, Evrysthenis Vartholomatos, Natalia Zacharopoulou, Eftichia Tsoumeleka, Georgios Gkizas, Georgios Bozios, Pericles Tsekeris, Ieremias Chousidis, Ioannis Leonardos, Andreas G. Tzakos, Athanasios P. Kyritsis & George A. Alexiou. (2021) Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro. Biomedicines 9:11, pages 1562.
Crossref
Evrysthenis Vartholomatos, George Vartholomatos, George Alexiou & Georgios Markopoulos. (2021) The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies. Methods and Protocols 4:1, pages 11.
Crossref
Anastasia Laevskaya, Anton Borovjagin, Peter S. Timashev, Maciej S. Lesniak & Ilya Ulasov. (2021) Metabolome-Driven Regulation of Adenovirus-Induced Cell Death. International Journal of Molecular Sciences 22:1, pages 464.
Crossref
Cynthia Kassab, Brittany Parker Kerrigan, Hillary Caruso, Sanaalarab Al Enazy & Amy B. Heimberger. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery 297 334 .
Dipongkor Saha, Robert L. Martuza & William T. CurryJr.Jr.. 2016. Neurotropic Viral Infections. Neurotropic Viral Infections 481 517 .
Kui Wang, Forrest M. Kievit, Mike Jeon, John R. Silber, Richard G. Ellenbogen & Miqin Zhang. (2015) Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma. Advanced Healthcare Materials 4:17, pages 2719-2726.
Crossref
George A. Alexiou, Konstantinos I. Tsamis, Evrysthenis Vartholomatos, Evangelia Peponi, Eftychia Tzima, Ifigeneia Tasiou, Efstathios Lykoudis, Pericles Tsekeris & Athanasios P. Kyritsis. (2015) Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells. Journal of Neuro-Oncology 123:2, pages 217-224.
Crossref
Drew A Spencer, Jacob S Young, Deepak Kanojia, Julius W Kim, Sean P Polster, Jason P Murphy & Maciej S Lesniak. (2015) Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy. Therapeutic Delivery 6:4, pages 453-468.
Crossref
George A. Alexiou, Konstantinos I. Tsamis & Athanasios P. Kyritsis. (2015) Targeting Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas. Seminars in Pediatric Neurology 22:1, pages 35-39.
Crossref
. 2015. Diagnostic Pathology: Infectious Diseases. Diagnostic Pathology: Infectious Diseases I-1-2 I-1-5 .
I.V. Ulasov, A.V. Borovjagin, B.A. Schroeder & A.Y. Baryshnikov. (2014) Oncolytic adenoviruses: A thorny path to glioma cure. Genes & Diseases 1:2, pages 214-226.
Crossref
George A. Alexiou, Xanthi Xourgia, Evrysthenis Vartholomatos, Spyridon Tsiouris, John A. Kalef-Ezra, Andreas D. Fotopoulos & Athanasios P. Kyritsis. (2014) Comparison of 99m Tc-Tetrofosmin and 99m Tc-Sestamibi Uptake in Glioma Cell Lines: The Role of P-Glycoprotein Expression . International Journal of Molecular Imaging 2014, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.